Table 4 Vaccine CE: experimental attributes and levels
From: A choice experiment assessment of stated early response to COVID-19 vaccines in the USA
Attribute | Levels |
|---|---|
Out-of-pocket cost [$] | $0, $50, $100, $175 |
Effectiveness [%] | 20%, 40%, 60%, 80% |
Days for antibodies to develop | 7, 14, 21 days |
Duration of protection [months] | 3, 6, 12 months |
Number of people out of 10 with mild side effects | 1, 3, 5 out of 10 |
Number of people out of 1,000,000 with severe side effects | 1, 10, 100 out of 1,000,000 |
Who recommends this specific vaccine | PCP (base), CDC, WHO, Media |
Country where vaccine was developed | Germany (base), USA, UK, China |
When vaccine was developed [months] | 3, 6 months |